Abstract | INTRODUCTION AND AIM: MATERIAL AND METHODS: In 103 patients with type 1 diabetes genetic analysis of PPARg2 polymorphism, C-peptide measurements and evaluation of BMI and clinical parameters were performed. Control group consisted of 109 healthy subjects. RESULTS: In diabetic patients, only three individuals exhibited Ala 12 Ala genotype (2.9%) and 29 patients were heterozygous Ala 12 Pro (28.2%). Interestingly, Ala12+ variants were associated with higher C-peptide levels in 6 th , 12 th and 24 th months after the onset than Pro 12 Pro genotype (0.39±0.24 pmol/mL vs. 0.22±0.14 pmol/mL, P=0.007 and 0.19±0.09 vs. 0.11±0.07, P=0.01 and 0.13±0.09 vs. 0.07±0.05, P=0.021, respectively). Similarly, C-peptide was also significantly increased in patients with history of type 2 diabetes in the first-degree relatives. The observation was even more evident when Ala12+ variants were taken together with family history of type 2 diabetes. Besides, in 24 th and 36 th months after the onset, Ala12+ variants revealed to be associated with higher BMI normalized by age and sex as compared to Pro 12 Pro (0.557±0.84 vs. -0.119±0.73, P=0.001 and 0.589±0.919 vs. 0.066±0.630, P=0.016, respectively). CONCLUSIONS:
|
Authors | Agnieszka Zmyslowska, Agnieszka Szadkowska, Beata Mianowska, Iwona Pietrzak, Krystyna Wyka, Wojciech Mlynarski |
Journal | Pediatric endocrinology, diabetes, and metabolism
(Pediatr Endocrinol Diabetes Metab)
Vol. 20
Issue 3
Pg. 88-94
( 2015)
ISSN: 2081-237X [Print] Poland |
PMID | 26615044
(Publication Type: Comparative Study, Journal Article)
|
Copyright | © Polish Society for Pediatric Endocrinology and Diabetology. |
Chemical References |
|
Topics |
- Adolescent
- Body Mass Index
- C-Peptide
(metabolism)
- Child
- Diabetes Mellitus, Type 1
(blood, genetics)
- Female
- Genetic Predisposition to Disease
- Humans
- Insulin Resistance
(genetics)
- Male
- Obesity
(genetics)
- PPAR gamma
(genetics)
- Poland
- Polymorphism, Genetic
- Risk Factors
|